Bioline Rx reported $6.6M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Arca Biopharma USD 0 0 Mar/2025
Bio Path USD 0 0 Mar/2025
Bioline Rx USD 6.6M 116K Sep/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025